Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations

Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 298 shares of common stock on March 27, 2025, to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• On March 27, 2025, Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold 298 shares of the company's common stock.
• The sale was executed at a price of $2.84 per share.
• This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on March 26, 2025.
• Following the transaction, Adams beneficially owns 405,972 shares, which includes 240,407 shares underlying RSUs.
• The sale was conducted in accordance with Relay Therapeutics' policies regarding the vesting of RSUs, and Adams had no discretion over the sale.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sale of shares to cover tax obligations) and doesn't suggest any significant positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial condition.

Key Dates

Keywords

Relay Therapeutics, Brian Adams, Chief Legal Officer, stock sale, Form 4, RSUs, tax obligations, beneficial ownership